A carregar...
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors
The majority of patients with ovarian cancer will experience relapse and thus require second-line therapy. While platinum-based therapies are the primary treatments for refractory disease other options are required, particularly for those with partially platinum-sensitive disease as their response r...
Na minha lista:
| Publicado no: | Mol Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6256111/ https://ncbi.nlm.nih.gov/pubmed/30546893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1729 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|